ZA986365B - Novel method of treatment. - Google Patents

Novel method of treatment.

Info

Publication number: ZA986365B
Authority: ZA; South Africa
Prior art keywords: treatment; novel method; novel
Prior art date: 1997-07-18

Application number

ZA9806365A

Other languages

English (en)

Inventor

Robin Edwin Buckingham

Stephen Alistair Smith

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-18

Filing date

1998-07-17

Publication date

2000-01-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10816177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA986365(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-07-17 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2000-01-17 Publication of ZA986365B publication Critical patent/ZA986365B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Thiazole And Isothizaole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

ZA9806365A 1997-07-18 1998-07-17 Novel method of treatment. ZA986365B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9715306A GB9715306D0 (en)	1997-07-18	1997-07-18	Novel method of treatment

Publications (1)

Publication Number	Publication Date
ZA986365B true ZA986365B (en)	2000-01-17

Family

ID=10816177

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9806365A ZA986365B (en)	1997-07-18	1998-07-17	Novel method of treatment.

Country Status (41)

Country	Link
EP (1)	EP0998291B2 (xx)
JP (2)	JP2001510158A (xx)
KR (1)	KR100680667B1 (xx)
CN (1)	CN1264302A (xx)
AP (1)	AP1318A (xx)
AR (2)	AR016768A1 (xx)
AT (1)	ATE366577T1 (xx)
AU (1)	AU743269B2 (xx)
BG (1)	BG64892B1 (xx)
BR (1)	BR9810904A (xx)
CA (1)	CA2297115C (xx)
CO (1)	CO4940422A1 (xx)
CY (1)	CY1107745T1 (xx)
CZ (1)	CZ302668B6 (xx)
DE (1)	DE69838066T3 (xx)
DK (1)	DK0998291T4 (xx)
DZ (1)	DZ2564A1 (xx)
EA (1)	EA003303B1 (xx)
ES (1)	ES2290989T5 (xx)
GB (1)	GB9715306D0 (xx)
HK (1)	HK1029272A1 (xx)
HU (1)	HU229119B1 (xx)
ID (1)	ID24198A (xx)
IL (1)	IL134045A0 (xx)
IN (1)	IN189035B (xx)
MA (1)	MA26522A1 (xx)
MY (1)	MY138246A (xx)
NO (1)	NO326356B1 (xx)
NZ (3)	NZ515555A (xx)
OA (1)	OA11632A (xx)
PE (1)	PE99799A1 (xx)
PL (2)	PL338127A1 (xx)
PT (1)	PT998291E (xx)
SI (1)	SI0998291T2 (xx)
SK (2)	SK288053B6 (xx)
TR (1)	TR200000135T2 (xx)
TW (1)	TW586926B (xx)
UA (1)	UA70302C2 (xx)
UY (1)	UY25103A1 (xx)
WO (1)	WO1999003476A1 (xx)
ZA (1)	ZA986365B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1897547A1 (en) *	1999-07-13	2008-03-12	Medicure Inc.	Use of pyridoxal phosphate derivatives for the treatment of diabetes and related complications
EP1832291A3 (en) *	1999-07-13	2009-11-04	Medicure Inc.	use of pyridoxal phosphate for the treatment of diabetes and related complications
US6586438B2 (en)	1999-11-03	2003-07-01	Bristol-Myers Squibb Co.	Antidiabetic formulation and method
US20010036479A1 (en)	2000-01-14	2001-11-01	Gillian Cave	Glyburide composition
CA2725833A1 (en)	2001-01-12	2002-07-18	Sun Pharmaceutical Industries Limited	Spaced drug delivery system
WO2005041962A1 (en)	2003-10-31	2005-05-12	Takeda Pharmaceutical Company Limited	Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
JP2008019169A (ja) *	2004-10-25	2008-01-31	Osaka Univ	新規ｐｐａｒ調節剤およびそのスクリーニング方法
AU2006328328B2 (en)	2005-12-22	2012-08-30	Takeda Pharmaceutical Company Limited	Solid preparation containing an insulin sensitizer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5522636A (en) *	1978-08-04	1980-02-18	Takeda Chem Ind Ltd	Thiazoliding derivative
JPS5697277A (en) *	1980-01-07	1981-08-05	Takeda Chem Ind Ltd	Thiazolidine derivative
JPS6051189A (ja) *	1983-08-30	1985-03-22	Sankyo Co Ltd	チアゾリジン誘導体およびその製造法
US4582839A (en) *	1984-03-21	1986-04-15	Takeda Chemical Industries, Ltd.	2,4-thiazolidinediones
CN1003445B (zh) *	1984-10-03	1989-03-01	武田药品工业株式会社	噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) *	1985-06-10	1994-01-05	武田薬品工業株式会社	チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) *	1986-07-24	1989-03-14	Takeda Chemical Industries, Ltd.	Method for producing thiazolidinedione derivatives
DE3856378T2 (de) *	1987-09-04	2000-05-11	Beecham Group P.L.C., Brentford	Substituierte Thiazolidindionderivate
US4791125A (en) *	1987-12-02	1988-12-13	Pfizer Inc.	Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008651A1 (en) *	1988-03-08	1989-09-21	Pfizer Inc.	Hypoglycemic thiazolidinedione derivatives
US5061717A (en) *	1988-03-08	1991-10-29	Pfizer Inc.	Thiazolidinedione hypoglycemic agents
WO1991007107A1 (en) *	1989-11-13	1991-05-30	Pfizer Inc.	Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) *	1990-12-06	1992-07-31	Terumo Corp	チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) *	1991-04-11	1993-02-02	Takeda Chemical Industries, Ltd.	Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
ATE139130T1 (de) *	1991-08-16	1996-06-15	Sandoz Ag	Inhalator zur verabreichung von pulverförmigen substanzen
ES2101866T3 (es) *	1991-08-26	1997-07-16	Upjohn Co	Producto alimentario liquido que contiene acido 3-guanidinopropionico.
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
TWI238064B (en) *	1995-06-20	2005-08-21	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) *	1997-02-19	1999-01-12	Warner-Lambert Company	Sulfonylurea-glitazone combinations for diabetes

1997
- 1997-07-18 GB GB9715306A patent/GB9715306D0/en active Pending
1998
- 1998-07-15 DZ DZ980174A patent/DZ2564A1/xx active
- 1998-07-16 SK SK89-2005A patent/SK288053B6/sk not_active IP Right Cessation
- 1998-07-16 CN CN98807221A patent/CN1264302A/zh active Pending
- 1998-07-16 PL PL98338127A patent/PL338127A1/xx not_active Application Discontinuation
- 1998-07-16 IL IL13404598A patent/IL134045A0/xx unknown
- 1998-07-16 BR BR9810904-9A patent/BR9810904A/pt not_active Application Discontinuation
- 1998-07-16 DE DE69838066T patent/DE69838066T3/de not_active Expired - Lifetime
- 1998-07-16 AP APAP/P/2000/001734A patent/AP1318A/en active
- 1998-07-16 EA EA200000141A patent/EA003303B1/ru not_active IP Right Cessation
- 1998-07-16 JP JP2000502775A patent/JP2001510158A/ja not_active Withdrawn
- 1998-07-16 PL PL375989A patent/PL199125B1/pl unknown
- 1998-07-16 PT PT98935126T patent/PT998291E/pt unknown
- 1998-07-16 MA MA25173A patent/MA26522A1/fr unknown
- 1998-07-16 HU HU0003634A patent/HU229119B1/hu unknown
- 1998-07-16 CZ CZ20000173A patent/CZ302668B6/cs not_active IP Right Cessation
- 1998-07-16 EP EP98935126A patent/EP0998291B2/en not_active Expired - Lifetime
- 1998-07-16 OA OA1200000014A patent/OA11632A/en unknown
- 1998-07-16 SI SI9830892T patent/SI0998291T2/sl unknown
- 1998-07-16 ES ES98935126T patent/ES2290989T5/es not_active Expired - Lifetime
- 1998-07-16 UA UA2000010215A patent/UA70302C2/uk unknown
- 1998-07-16 PE PE1998000631A patent/PE99799A1/es not_active Application Discontinuation
- 1998-07-16 TR TR2000/00135T patent/TR200000135T2/xx unknown
- 1998-07-16 ID IDW20000074A patent/ID24198A/id unknown
- 1998-07-16 NZ NZ515555A patent/NZ515555A/xx not_active IP Right Cessation
- 1998-07-16 AT AT98935126T patent/ATE366577T1/de active
- 1998-07-16 CA CA2297115A patent/CA2297115C/en not_active Expired - Lifetime
- 1998-07-16 DK DK98935126.7T patent/DK0998291T4/da active
- 1998-07-16 AU AU84487/98A patent/AU743269B2/en not_active Expired
- 1998-07-16 NZ NZ520652A patent/NZ520652A/en not_active IP Right Cessation
- 1998-07-16 WO PCT/GB1998/002109 patent/WO1999003476A1/en active IP Right Grant
- 1998-07-16 SK SK60-2000A patent/SK287823B6/sk not_active IP Right Cessation
- 1998-07-16 NZ NZ501256A patent/NZ501256A/xx not_active IP Right Cessation
- 1998-07-16 KR KR1020007000513A patent/KR100680667B1/ko not_active IP Right Cessation
- 1998-07-17 TW TW087111768A patent/TW586926B/zh not_active IP Right Cessation
- 1998-07-17 MY MYPI98003290A patent/MY138246A/en unknown
- 1998-07-17 AR ARP980103516A patent/AR016768A1/es not_active Application Discontinuation
- 1998-07-17 ZA ZA9806365A patent/ZA986365B/xx unknown
- 1998-07-17 CO CO98040748A patent/CO4940422A1/es unknown
- 1998-07-17 UY UY25103A patent/UY25103A1/es not_active IP Right Cessation
- 1998-07-20 IN IN2089DE1998 patent/IN189035B/en unknown
1999
- 1999-06-18 AR ARP990102953A patent/AR019331A2/es unknown
2000
- 2000-01-17 NO NO20000229A patent/NO326356B1/no not_active IP Right Cessation
- 2000-02-08 BG BG104139A patent/BG64892B1/bg active Active
- 2000-10-24 HK HK00106765A patent/HK1029272A1/xx not_active IP Right Cessation
2005
- 2005-04-21 JP JP2005123586A patent/JP2005247865A/ja active Pending
2007
- 2007-09-27 CY CY20071101241T patent/CY1107745T1/el unknown

Also Published As

Publication number	Publication date
CY1107745T1 (el)	2013-04-18
MA26522A1 (fr)	2004-12-20
EA200000141A1 (ru)	2000-08-28
EP0998291B2 (en)	2011-07-06
PT998291E (pt)	2007-10-11
UA70302C2 (uk)	2004-10-15
PL338127A1 (en)	2000-09-25
EP0998291B1 (en)	2007-07-11
SI0998291T1 (sl)	2007-12-31
DE69838066D1 (de)	2007-08-23
ATE366577T1 (de)	2007-08-15
PL199125B1 (pl)	2008-08-29
TW586926B (en)	2004-05-11
DE69838066T3 (de)	2012-03-29
ID24198A (id)	2000-07-13
SK288053B6 (sk)	2013-03-01
UY25103A1 (es)	2000-12-29
HUP0003634A3 (en)	2003-04-28
SK287823B6 (sk)	2011-11-04
DE69838066T2 (de)	2008-03-20
EA003303B1 (ru)	2003-04-24
CA2297115C (en)	2010-02-23
CO4940422A1 (es)	2000-07-24
WO1999003476A1 (en)	1999-01-28
KR20010021948A (ko)	2001-03-15
DZ2564A1 (fr)	2003-02-15
CZ2000173A3 (en)	2001-05-16
NO20000229L (no)	2000-01-17
EP0998291A1 (en)	2000-05-10
HK1029272A1 (en)	2001-03-30
MY138246A (en)	2009-05-29
ES2290989T5 (es)	2011-11-11
JP2001510158A (ja)	2001-07-31
NO326356B1 (no)	2008-11-17
SK602000A3 (en)	2000-07-11
KR100680667B1 (ko)	2007-02-09
AR019331A2 (es)	2002-02-13
OA11632A (en)	2004-11-22
GB9715306D0 (en)	1997-09-24
IN189035B (xx)	2002-12-07
CZ302668B6 (cs)	2011-08-24
HU229119B1 (en)	2013-08-28
PE99799A1 (es)	1999-12-22
DK0998291T3 (da)	2007-11-05
CN1264302A (zh)	2000-08-23
AP1318A (en)	2004-10-22
ES2290989T3 (es)	2008-02-16
BG104139A (en)	2000-11-30
TR200000135T2 (tr)	2000-05-22
JP2005247865A (ja)	2005-09-15
NZ515555A (en)	2002-09-27
HUP0003634A2 (hu)	2001-07-30
AP2000001734A0 (en)	2000-03-31
AU743269B2 (en)	2002-01-24
NZ520652A (en)	2004-06-25
BG64892B1 (bg)	2006-08-31
AR016768A1 (es)	2001-08-01
CA2297115A1 (en)	1999-01-28
IL134045A0 (en)	2001-04-30
NZ501256A (en)	2002-09-27
AU8448798A (en)	1999-02-10
NO20000229D0 (no)	2000-01-17
SI0998291T2 (sl)	2011-10-28
BR9810904A (pt)	2000-09-26
DK0998291T4 (da)	2011-09-26

Publication	Publication Date	Title
ZA200108446B (en)	2003-08-27	Novel method of treatment.
GB9617780D0 (en)	1996-10-02	Method of treatment
ZA986363B (en)	2000-01-17	Novel method of treatment.
ZA985237B (en)	2000-02-17	Novel method of treatment.
GB9605828D0 (en)	1996-05-22	Treatment method
GB9707693D0 (en)	1997-06-04	Novel method of treatment
ZA986364B (en)	2000-01-17	Novel method of treatment.
ZA986365B (en)	2000-01-17	Novel method of treatment.
ZA977867B (en)	1998-05-27	Method of treatment.
GB9714841D0 (en)	1997-09-17	Treatment method
ZA200007396B (en)	2002-02-27	Method of treatment.
AP2005003432A0 (en)	2005-12-31	Novel method of treatment.
ZA985236B (en)	2000-02-17	Novel method of treatment.
ZA985238B (en)	2000-02-17	Novel method of treatment.
ZA985235B (en)	2000-02-17	Novel method of treatment.
GB9717399D0 (en)	1997-10-22	Method of treatment
GB9724289D0 (en)	1998-01-14	Method of treatment
ZA963472B (en)	1998-02-02	Method of treatment.
GB9703102D0 (en)	1997-04-02	Treatment method
EG24158A (en)	2008-08-20	Novel method of treatment
GB9824790D0 (en)	1999-01-06	Novel method of treatment
GB9824871D0 (en)	1999-01-06	Novel method of treatment
GB9824789D0 (en)	1999-01-06	Novel method of treatment
SI1135128T1 (sl)	2007-12-31	Nov postopek zdravljenja
GB9701448D0 (en)	1997-03-12	Methods of treatment